| 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ... The Lancet 393 (10191), 2599-2612, 2019 | 293 | 2019 |
| COVID-19: Global radiation oncology’s targeted response for pandemic preparedness R Simcock, TV Thomas, C Estes, AR Filippi, MS Katz, IJ Pereira, H Saeed Clinical and Translational Radiation Oncology 22, 55-68, 2020 | 242 | 2020 |
| Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of … X Pivot, J Gligorov, V Müller, G Curigliano, A Knoop, S Verma, V Jenkins, ... Annals of oncology 25 (10), 1979-1987, 2014 | 182 | 2014 |
| ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer R Simcock, L Fallowfield, K Monson, I Solis-Trapala, L Parlour, ... Annals of oncology 24 (3), 776-783, 2013 | 145 | 2013 |
| PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with … HM Earl, L Hiller, AL Vallier, S Loi, D Howe, HB Higgins, K McAdam, ... Journal of Clinical Oncology 36 (15_suppl), 506-506, 2018 | 89 | 2018 |
| Beyond performance status R Simcock, J Wright Clinical Oncology 32 (9), 553-561, 2020 | 78 | 2020 |
| Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice S Heath, V Willis, K Allan, K Purdie, C Harwood, P Shields, R Simcock, ... Clinical oncology 24 (1), e18-e23, 2012 | 61 | 2012 |
| Subcutaneous Trastuzumab (Herceptin®): A UK Time and Motion Study in Comparison with Intravenous Formulation for the Treatment of Patients with HER2 … R Burcombe, S Chan, R Simcock, K Samanta, F Percival, P Barrett-Lee Advances in Breast Cancer Research 2 (04), 133-140, 2013 | 56 | 2013 |
| Follow-up and survivorship in head and neck cancer R Simcock, R Simo Clinical Oncology 28 (7), 451-458, 2016 | 55 | 2016 |
| Erlotinib induced skin rash spares skin in previous radiotherapy field. SS Mitra, R Simcock Journal of Clinical Oncology: Official Journal of the American Society of …, 2006 | 53 | 2006 |
| Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer NML Battisti, MWR Reed, E Herbert, JL Morgan, KA Collins, SE Ward, ... European Journal of Cancer 144, 269-280, 2021 | 46 | 2021 |
| Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified … L Wyld, MWR Reed, J Morgan, K Collins, S Ward, GR Holmes, ... European Journal of Cancer 142, 48-62, 2021 | 38 | 2021 |
| Group acupuncture to relieve radiation induced xerostomia: a feasibility study R Simcock, L Fallowfield, V Jenkins Acupuncture in Medicine 27 (3), 109-113, 2009 | 38 | 2009 |
| Handbook of metastatic breast cancer C Swanton, SRD Johnston CRC Press, 2011 | 33 | 2011 |
| Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival … L Wyld, MWR Reed, K Collins, M Burton, K Lifford, A Edwards, S Ward, ... British journal of surgery 108 (5), 499-510, 2021 | 31 | 2021 |
| Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer A Ring, NML Battisti, MWR Reed, E Herbert, JL Morgan, M Bradburn, ... British Journal of Cancer 125 (2), 209-219, 2021 | 30 | 2021 |
| Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits LJ Fallowfield, SL Catt, SF May, L Matthews, VM Shilling, R Simcock, ... Supportive Care in Cancer 25, 237-244, 2017 | 29 | 2017 |
| Costs of multidisciplinary teams in cancer are small in relation to benefits R Simcock, A Heaford BMJ 344, 2012 | 23 | 2012 |
| Acute oncology service: assessing the need and its implications D Mansour, R Simcock, DC Gilbert Clinical Oncology 23 (3), 168-173, 2011 | 22 | 2011 |
| The cost of oropharyngeal cancer in England: a retrospective hospital data analysis ST Keeping, MJ Tempest, SJ Stephens, SM Carroll, R Simcock, TM Jones, ... Clinical Otolaryngology 43 (1), 223-229, 2018 | 19 | 2018 |
Matthew S. KatzRadiation Oncology Associates, PAVerified email at lowellgeneral.org
